DEA Revokes Mississippi Doctor's Controlled Substances Registration Permanently
Published Date: 3/20/2025
Notice
Summary
Dr. Hazem Barmada from Mississippi lost his medical license and didn’t keep his DEA registration up to date, so the DEA officially revoked his permission to handle controlled substances. This affects Dr. Barmada directly, stopping him from legally working with these drugs. The decision is final, and it means no more controlled substance handling for him starting now.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Registration Revoked for Dr. Barmada
The DEA revoked Hazem Barmada, M.D.'s Certificate of Registration No. BB4130162 and denied any pending applications to renew, modify, or obtain additional registration in Mississippi. The Agency found Dr. Barmada voluntarily surrendered his Mississippi medical license on November 18, 2021, and his DEA registration had expired on July 31, 2024. The Order is effective April 21, 2025.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-04767, Notice of Record of Decision for the Environmental Impact Statement Expansion of Childcare Services North of the Eglin Test and Training Complex, Eglin Air Force Base, Florida
The Air Force is building a brand-new Child Development Center north of the Eglin Test and Training Complex in Florida to help military families with childcare. They’ll buy 14 acres from Crestview, and the 96th Force Support Squadron will run the center. This decision was finalized in early 2025 after careful review and public input, making life easier for families on base soon!
Next: 2025-04770, Agency Information Collection Activities; Extension, Without Change, of a Currently Approved Collection: Training Plan for Science, Technology, Engineering, and Mathematics (STEM) Optional Practical Training (OPT) Students
The Department of Homeland Security is keeping the current form for STEM OPT students’ training plans without any changes. This means students and employers involved in STEM Optional Practical Training can continue using the same paperwork. Comments on this decision are open until May 19, 2025, and there’s no new cost or extra hassle expected.